Literature DB >> 16670079

Expression and prognostic significance of heat-shock proteins in myelodysplastic syndromes.

Amélie Duval, Daniela Olaru, Lydia Campos, Pascale Flandrin, Nathalie Nadal, Denis Guyotat.   

Abstract

Using flow cytometry, we investigated the clinical and hematologic relevance of expression of heat-shock proteins (HSP) HSP27, HSP60, HSP70, HSP90 and HSP110 in bone marrow of 142 patients with newly diagnosed myelodysplastic syndromes, together with that of the membrane differentiation antigen CD34 and the drug-resistance related protein, P170 (Pgp).

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16670079

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


  10 in total

Review 1.  The human HSP70 family of chaperones: where do we stand?

Authors:  Jürgen Radons
Journal:  Cell Stress Chaperones       Date:  2016-02-10       Impact factor: 3.667

2.  Combination of HDE and BIIB021 efficiently inhibits cell proliferation and induces apoptosis via downregulating hTERT in myelodysplastic syndromes.

Authors:  Bo Wang; Jianping Jiang; Yun Zhang; Yingying Shen; Liqiang Wu; Siqi Tang; Shengyun Lin
Journal:  Exp Ther Med       Date:  2021-03-17       Impact factor: 2.447

3.  Differential heat shock protein localization in chronic lymphocytic leukemia.

Authors:  Nina C Dempsey; Francesca Leoni; H Elyse Ireland; Christine Hoyle; John H H Williams
Journal:  J Leukoc Biol       Date:  2009-12-10       Impact factor: 4.962

4.  MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL.

Authors:  Ana E Rodríguez-Vicente; Dalia Quwaider; Rocío Benito; Irena Misiewicz-Krzeminska; María Hernández-Sánchez; Alfonso García de Coca; Rosa Fisac; José-María Alonso; Carolina Zato; Juan Francisco de Paz; Juan Luis García; Ma Eugenia Sarasquete; José Ángel Hernández; Juan M Corchado; Marcos González; Norma C Gutiérrez; Jesús-María Hernández-Rivas
Journal:  BMC Cancer       Date:  2015-04-08       Impact factor: 4.430

5.  BIIB021, an Hsp90 inhibitor, effectively kills a myelodysplastic syndrome cell line via the activation of caspases and inhibition of PI3K/Akt and NF-κB pathway proteins.

Authors:  Shengyun Lin; Jing Li; Wenjing Zhou; Wenbin Qian; Bo Wang; Zhi Chen
Journal:  Exp Ther Med       Date:  2014-03-28       Impact factor: 2.447

Review 6.  Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach.

Authors:  Suman Chatterjee; Timothy F Burns
Journal:  Int J Mol Sci       Date:  2017-09-15       Impact factor: 5.923

Review 7.  Heat shock proteins: essential proteins for apoptosis regulation.

Authors:  D Lanneau; M Brunet; E Frisan; E Solary; M Fontenay; C Garrido
Journal:  J Cell Mol Med       Date:  2008-02-08       Impact factor: 5.310

8.  Heat Shock Protein 90 is overexpressed in high-risk myelodysplastic syndromes and associated with higher expression and activation of Focal Adhesion Kinase.

Authors:  Pascale Flandrin-Gresta; Françoise Solly; Carmen Mariana Aanei; Jérôme Cornillon; Emmanuelle Tavernier; Nathalie Nadal; Franck Morteux; Denis Guyotat; Eric Wattel; Lydia Campos
Journal:  Oncotarget       Date:  2012-10

9.  Inhibiting the molecular evolution of cancer through HSP90.

Authors:  Ana Sofia Martins; Faith E Davies; Paul Workman
Journal:  Oncotarget       Date:  2012-10

Review 10.  Heat Shock Proteins and PD-1/PD-L1 as Potential Therapeutic Targets in Myeloproliferative Neoplasms.

Authors:  Steven De Almeida; Mathilde Regimbeau; Gaëtan Jego; Carmen Garrido; François Girodon; François Hermetet
Journal:  Cancers (Basel)       Date:  2020-09-11       Impact factor: 6.639
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.